Single-cell transcriptome sequencing-based analysis: probing the mechanisms of glycoprotein NMB regulation of

Shaoqi Yang1,2, Yuheng Sun1,2, Min Long3

  • 1Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Physiology, School of Medicine, Zhongda Hospital, Southeast University, 87 Dingjiaqiao Rd, Nanjing, Jiangsu, 210009, China.

PubMed

Insights

Glycoprotein non-metastatic melanoma protein B (GPNMB) drives silicosis progression by promoting epithelial-to-mesenchymal transition in lung cells. Targeting GPNMB may offer a new strategy for preventing pulmonary fibrosis caused by silica exposure.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Toxicology

Background:

  • Silicosis is a severe occupational lung disease with limited treatment options.
  • Epithelial-mesenchymal transition (EMT) is implicated in disease but its role in silicosis is not well understood.

Purpose of the Study:

  • To investigate the molecular mechanisms of pulmonary fibrosis in silicosis.
  • To explore the role of EMT in silicosis pathogenesis at the single-cell level.

Main Methods:

  • Construction of a mouse model for experimental silicosis.
  • Single-cell transcriptome sequencing to analyze cellular changes.
  • Investigation of glycoprotein non-metastatic melanoma protein B (GPNMB) function.

Main Results:

  • GPNMB promotes EMT in alveolar type II epithelial cells, accelerating proliferation and migration.
  • GPNMB-containing extracellular vesicles contribute to silicosis progression and alter extracellular matrix.
  • Sustained GPNMB activity leads to persistent pulmonary pathological changes.

Conclusions:

  • GPNMB plays a critical role in driving EMT and fibrosis in silicosis.
  • GPNMB is a potential therapeutic target for preventing silica-induced pulmonary fibrosis.

Related Concept Videos